Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Pharmacological Research|July 26, 2021
The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironmentHanyu Zhang, Min Yang, Xu Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 27, 2024
Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulationMin Yang, Qianxiu Li, Huan Yang, et al.
Frontiers in Oncology|December 16, 2022
Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancerYalan Dai, Liqiong Yang, Abass Sakandar, et al.
Acta Pharmaceutica Sinica. B|September 23, 2020
Conditional reprogramming: next generation cell cultureXiaoxiao Wu, Shengpeng Wang, Mingxing Li, et al.
International Journal of Molecular Medicine|April 3, 2020
CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cellsJianhua Yin, Hanyu Zhang, Xu Wu, et al.
Current Medicinal Chemistry|January 14, 2025
Structural Modifications and Prospects of Histone Deacetylase (HDAC) Inhibitors in CancerYu Chen, Jiahong Su, Sha Li, et al.
Frontiers in Oncology|July 26, 2024
The investigation of oncolytic viruses in the field of cancer therapyZijun Yuan, Yinping Zhang, Xiang Wang, et al.
Cancers|September 9, 2022
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and ChallengesYueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Frontiers in Immunology|March 12, 2025
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinomaSiqi Ren, Yinping Zhang, Xingyue Wang, et al.
Molecular Biotechnology|September 8, 2023
LncRNA RP11-93B14.5 promotes gastric cancer cell growth through PI3K/AKT signaling pathwayQianxiu Li, Zhongxiu Zhu, Hanyu Zhang, et al.
Pageof 11